TRINITY BIOTECH PLC-SPON ADR (TRIB)
US8964385046 - ADR
ChartMill assigns a Buy % Consensus number of 86% to TRIB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.06. This target is 67.21% above the current price.
TRIB was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about TRIB.
In the previous month the buy percentage consensus was at a similar level.
TRIB was analyzed by 7 analysts. More opinions would make the average more meaningful.